Commentary: Surgery versus stereotactic body radiation therapy for patients with renal dysfunction and non-small cell lung cancer: The answer is still not clear

J Thorac Cardiovasc Surg. 2022 Jul;164(1):240-241. doi: 10.1016/j.jtcvs.2021.11.034. Epub 2021 Nov 20.

Author

Stephanie H Chang¹

Affiliation

¹ Division of Thoracic Surgery, Department of Cardiothoracic Surgery, New York University Langone Health, New York, NY. Electronic address: stephanie.chang@nyulangone.org.

PMID: 34865839
DOI: 10.1016/j.jtcvs.2021.11.034

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung* / pathology
Carcinoma, Non-Small-Cell Lung* / radiotherapy
Carcinoma, Non-Small-Cell Lung* / surgery
Humans
Kidney Diseases*
Lung / surgery
Lung Neoplasms* / pathology
Lung Neoplasms* / radiotherapy
Lung Neoplasms* / surgery
Neoplasm Staging
Radiosurgery* / adverse effects
Treatment Outcome